We think Biogen's neurology, immunology, and focus on rare diseases support a narrow moat. Biogen's strategy has its roots in the 2003 merger of Biogen (Avonex for treating multiple sclerosis, or MS) ...
Outrage against PBMs was on full display when 400 pharmacy professionals in Kansas shuttered their businesses and petitioned ...
Economist Ali Yurukoglu has some encouraging news for anyone who fears that an overconcentration of corporate power is ...
Google is fighting to overturn a jury verdict that found its Play Store an illegal monopoly, urging a federal appeals court ...
Spirits giant Diageo said U.S. tariffs on goods from Mexico and Canada could amount to a $200 million hit on its annual operating profit. Imports from Canada and Mexico represent about 45% of Diageo’s ...
The pharma major beat analysts’ expectations in the fourth quarter of 2024, despite looming competition for its top heart drug Entresto.
Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. Apple’s quarterly profits and revenue crept past Wall Street forecasts, despite lower iPhone sales as it ...
Contrary to the spun narrative of innovation and entrepreneurial genius, Silicon Valley's rise is a story of calculated ...
a significant drop from the $7.9 billion profit recorded during the same period in 2023. This downturn comes at a time when competition in the electric vehicle market is ramping up, putting pressure ...
(Reuters) – Indian consumer electrical company R R Kabel reported a 3% fall in third-quarter profit on Tuesday, as stiff competition squeezed its margins from the wires segment. The company’s ...
President Donald Trump said the launch of a low-cost Chinese AI model should be seen as a wake up call for U.S. industries. Trump also announced plans to impose new tariffs on semiconductor imports.
Jan 28 (Reuters) - Indian consumer electrical company R R Kabel (RRKA.NS), opens new tab reported a 3% fall in third-quarter profit on Tuesday, as stiff competition squeezed its margins from the ...